https://en.cytoniche.com/news/186.html
We are thrilled to share an extraordinary achievement in our journey at CytoNiche! Today marks a historic milestone as our esteemed partner, Platinum Life, has achieved a remarkable feat in the biotechnology realm.According to recent disclosures from the China National Medical Products Administration (NMPA), Platinum Life has secured formal acceptance for the New Drug Application (NDA) of "Amimestrocel Injection" — the first stem cell drug in China's history to enter the priority review phase. This groundbreaking therapy targets steroid-refractory acute graft-versus-host disease (aGVHD), demonstrating exceptional safety and efficacy during Phase III clinical trials.
Cell Therapy News/Articles, page-18031
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |